Interactions industry

ADDN has interactions and collaborations with many industrial partners.
A few examples of IWT- or FP7-funded projects with industrial partners are indicated below:


OpenMedChem: Medicinal Chemistry Open Innovation Doctorates -Tuberculosis 

Funding: Initial Training Network (MCA, FP7)
                From: 01/10/2012 to 30/09/2016

Participant: Lab. of Medicinal Chemistry (UAMC)


  • Project:
    Benzodiazepine analogues for antifungal research
    • Participants: Lab. of Microbiology, Parasitology and Hygiene (LMPH), Lab. of Medicinal Chemistry (UAMC)
  • Project:
    Immuno-PET: Immuno-positron emission tomography (PET) imaging as a potential biomarker for diagnosis and treatment in Alzheimer's disease.

    This is a collaborative project with MICA & Laboratory for Translational Neuroscience.
    • Funding: IWT O&O (IWT Activity Report 2012)
    • Participant: Laboratory of Medicinal Chemistry (UAMC)


Dafra Pharma

Extensive pharmacological study of the new anti-leishmania candidate drug oleylphosphocholine (OIPC) and exploration of other therapeutic applications to maximize the valorization value. 


  • IWT SME (IWT Activity Report 2011)

Participant: Lab. of Microbiology, Parasitology and Hygiene (LMPH)